Long-term hyperglycemia aggravates -synuclein aggregation and dopaminergic neuronal loss in a Parkinsons disease mouse model
Mounjaro FDA Safety Label Change Ozempic (semaglutide) subcutaneous weekly injection FDA Approval Year: 2017 Ozempic FDA Safety Label Change Rybelsus (active ingredient: semaglutide) once-daily pills FDA Approval Year: 2019 Rybelsus FDA Safety Label Change Soliqua 100/33 (insulin glargine and lixisenatide) subcutaneous daily injection FDA Approval Year: 2016 Soliqua FDA Safety Label Change Trulicity (dulaglutide) subcutaneous weekly injection FDA Approval Year: 2014 Clinical trials reports of stomach problems (gastrointestinal effects) added
Hydration changes appear sooner
Because semaglutide GLP-1 is usually increased slowly, the full effects may become stronger as the dosage reaches higher levels
People living in areas with high pollution : Long-term exposure to environmental pollutants like air pollution can increase oxidative stress and reduce glutathione levels
The fibrotic process is a dysregulated wound-healing response, driven by the persistent activation of fibroblasts (or myofibroblasts), which results in the deposition of excessive extracellular matrix (ECM) proteins such as collagen [4], a key feature of pathological tissue remodelling in fibrotic disorders [5,6,7,8]